Symptoms of Serotonin Irregularities
Serotonin Excess (Serotonin Syndrome)
Serotonin syndrome presents with a clinical triad of mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity, typically arising within 24-48 hours after combining serotonergic medications. 1
Clinical Presentation
The syndrome manifests across three distinct domains:
Mental Status Changes:
- Confusion
- Agitation
- Anxiety
- Delirium 2
Neuromuscular Hyperactivity:
- Tremors
- Clonus (spontaneous, inducible, or ocular) - highly diagnostic when present 2
- Hyperreflexia - highly diagnostic when present 2
- Muscle rigidity
- Myoclonus (occurs in 57% of cases, making it the most common finding) 2
Autonomic Hyperactivity:
- Hypertension
- Tachycardia
- Arrhythmias
- Tachypnea
- Diaphoresis (profuse sweating)
- Shivering
- Vomiting
- Diarrhea 1
Severe/Advanced Symptoms
When the syndrome progresses, life-threatening complications emerge:
- Fever (temperature >38°C or >41.1°C in severe cases)
- Seizures
- Cardiac arrhythmias
- Unconsciousness
- Rhabdomyolysis with elevated creatine kinase
- Metabolic acidosis
- Renal failure
- Disseminated intravascular coagulopathy 1, 2
The mortality rate is approximately 11%, with inadequate management being the most common cause of death. 2
Diagnostic Approach
The diagnosis is purely clinical based on recent exposure to serotonergic agents. The Hunter Criteria have higher sensitivity (84%) and specificity (97%) than older Sternbach criteria 2. According to modified Dunkley criteria, diagnosis requires serotonergic drug use within 5 weeks plus any of:
- Tremor AND hyperreflexia
- Spontaneous clonus
- Muscle rigidity, temperature >38°C, AND either ocular clonus or inducible clonus
- Ocular clonus AND either agitation or diaphoresis
- Inducible clonus AND either agitation or diaphoresis 2
Key clinical pearl: Clonus and hyperreflexia are highly diagnostic for serotonin syndrome when occurring with serotonergic drug use. 2
Serotonin Deficiency (SSRI Discontinuation Syndrome)
Abrupt discontinuation or missed doses of shorter-acting SSRIs produces a distinct withdrawal syndrome characterized by physical, neurological, and psychiatric symptoms. 1
Clinical Presentation
Physical Symptoms:
- Fatigue and lethargy
- General malaise
- Myalgias (muscle aches)
- Chills
- Headaches
- Nausea
- Vomiting
- Diarrhea 1
Neurological Symptoms:
- Dizziness
- Imbalance and vertigo
- Sensory disturbances
- Paresthesias (tingling sensations)
- Insomnia 1
Psychiatric Symptoms:
- Anxiety
- Irritability
- Agitation 1
Medication-Specific Risk
Paroxetine has the highest association with discontinuation syndrome, followed by fluvoxamine and sertraline (to a lesser extent). This relates to their shorter half-lives compared to fluoxetine. 1
Critical Clinical Pitfalls
Do not confuse behavioral activation with serotonin syndrome: Behavioral activation (restlessness, insomnia, impulsiveness) occurs early in treatment or with dose increases and resolves quickly with dose reduction. Serotonin syndrome requires drug combinations and presents with the characteristic triad. 1
Physical restraints are contraindicated in serotonin syndrome: They worsen hyperthermia and lactic acidosis through increased isometric muscle contractions, increasing mortality risk. 2
Approximately 25% of serotonin syndrome cases require ICU admission with intubation and mechanical ventilation. 2
The syndrome can occur even without medication changes: As demonstrated in recent case reports, delayed onset after stable medication regimens is possible, particularly with supplement interactions or after procedures like ECT. 3, 4